Biotech

All Articles

Gene publisher Volume laying off 131 employees

.Only days after gene publisher Volume Biosciences declared unrevealed functional cuts, a clearer pi...

Repare lays off 25% of team as biotech stops preclinical R&ampD

.Repare Therapeutics is giving up a quarter of its labor force as the oncology biotech scales back i...

J &amp J declare FDA authorization of $6.5 B autoimmune medicine

.Johnson &amp Johnson has taken another step toward understanding a gain on its $6.5 billion nipocal...

Gain's phase 1 win paves technique to verify Parkinson's medicine's worth

.Increase Rehabs has set its direct confirming the effectiveness of its own Parkinson's health condi...

Actinogen files brand new period 2 records to salvage depression medication

.Actinogen Medical's hopes-- and stock cost-- have actually rebounded slightly from earlier this mon...

Pfizer and also Crown jewel add Ratio to multibillion-dollar formula

.Main Pioneering as well as Pfizer have actually added Quotient into their 10-program relationship, ...

Bayer markers $547M treaty to press boundaries of noncoding RNA

.Bayer managers were eager to worry to Strong this summertime that the German pharma giant's craving...

UK introduces programs to launch 18 brand-new clinical test hubs

.Surrounded by a yearslong professional test downtrend in the U.K., a new public-private relationshi...

UPDATE: Genentech telegraphs 93 cutbacks in The golden state after sharing plans to shutter cancer immunology research study device

.Adhering to the statement of a huge cutback round in April and a significant rebuilding effort reve...

Neurocrine's KarXT opponent strikes in period 2-- yet only at low dosage

.Neurocrine Biosciences has actually obtained its hoped-for profile in a stage 2 schizophrenia test,...